We are live on ! Find out more
ALT icon

Altimmune
ALT

57 hedge funds and large institutions have $143M invested in Altimmune in 2020 Q2 according to their latest regulatory filings, with 34 funds opening new positions, 13 increasing their positions, 2 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

2,700% more capital invested

Capital invested by funds: $5.1M → $143M (+$138M)

550% more repeat investments, than reductions

Existing positions increased: 13 | Existing positions reduced: 2

467% more first-time investments, than exits

New positions opened: 34 | Existing positions closed: 6

254% more call options, than puts

Call options by funds: $15.6M | Put options by funds: $4.4M

97% more funds holding

Funds holding: 29 → 57 (+28)

55.93% more ownership

Funds ownership: 10.34% → 66.27% (+56%)

Holders
57
Holders Change
+28
Holders Change %
+96.55%
% of All Funds
1.17%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
34
Increased
13
Reduced
2
Closed
6
Calls
$15.6M
Puts
$4.4M
Net Calls
+$11.2M
Net Calls Change
+$10.7M

Top Buyers

1
VA
VR Adviser
New York
+$24.7M
2
BBA
Baker Bros. Advisors
New York
+$11.6M
3
Hudson Bay Capital Management
Hudson Bay Capital Management
Connecticut
+$4.29M
4
Citadel Advisors
Citadel Advisors
Florida
+$3.13M
5
BlackRock
BlackRock
New York
+$2.99M

Top Sellers

1
Victory Capital Management
Victory Capital Management
Texas
-$16K
2
APA
American Portfolios Advisors
New York
-$3.21K
3
GSWM
Golden State Wealth Management
California
-$3K
4
PAM
Panagora Asset Management
Massachusetts
-$3K
5
Osaic Holdings
Osaic Holdings
Arizona
-$1.1K
Name Holding Trade Value Shares
Change 		Change in
Stake
VA
1
VR Adviser
New York
$48.2M +$24.7M +4,500,000 New
BBA
2
Baker Bros. Advisors
New York
$22.6M +$11.6M +2,107,600 New
Renaissance Technologies
3
Renaissance Technologies
New York
$9.91M +$1.7M +308,700 +50%
Hudson Bay Capital Management
4
Hudson Bay Capital Management
Connecticut
$8.35M +$4.29M +780,000 New
Vanguard Group
5
Vanguard Group
Pennsylvania
$6.49M +$139K +25,336 +4%
BlackRock
6
BlackRock
New York
$6.22M +$2.99M +545,063 +1,505%
Citadel Advisors
7
Citadel Advisors
Florida
$6.09M +$3.13M +568,897 New
ACP
8
Acuta Capital Partners
California
$5.76M +$2.95M +537,500 New
Millennium Management
9
Millennium Management
New York
$5.42M +$2.78M +506,524 New
Bank of America
10
Bank of America
North Carolina
$3.24M +$1.66M +302,299 New
Invesco
11
Invesco
Georgia
$2.46M +$1.26M +229,659 New
FMBTD
12
First Midwest Bank Trust Division
Illinois
$2.39M +$1.23M +223,336 New
IC
13
Ikarian Capital
Texas
$1.77M +$906K +165,000 New
GTC
14
Ghost Tree Capital
New York
$1.61M +$824K +150,000 New
GPCM
15
Granite Point Capital Management
Massachusetts
$1.61M +$824K +150,000 New
WG
16
Winton Group
United Kingdom
$1.46M +$233K +42,365 +45%
Barclays
17
Barclays
United Kingdom
$1.28M +$658K +119,715 New
Northern Trust
18
Northern Trust
Illinois
$1.05M +$466K +84,796 +653%
Geode Capital Management
19
Geode Capital Management
Massachusetts
$953K +$15.7K +2,859 +3%
Dimensional Fund Advisors
20
Dimensional Fund Advisors
Texas
$518K – – –
Bank of New York Mellon
21
Bank of New York Mellon
New York
$454K – – –
BCM
22
Bridgeway Capital Management
Texas
$413K +$13.7K +2,500 +7%
VF
23
Virtu Financial
New York
$412K +$211K +38,460 New
Goldman Sachs
24
Goldman Sachs
New York
$411K +$211K +38,386 New
UBS Group
25
UBS Group
Switzerland
$403K +$204K +37,145 +7,429%
1
2 3

ALT Hedge Fund Activity: Q2 2020 in Review

57 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Altimmune (ALT) for Q2 2020, worth a combined $143M — up 2,700% from $5.1M a quarter earlier.

Buyers outnumbered sellers: 34 funds opened new ALT positions and 6 closed out — a net gain of 28 holders — while 13 added to existing stakes and 2 trimmed.

The largest buyer was VR Adviser, opening a new position worth an estimated $24.7M. The largest seller was Victory Capital Management, exiting entirely with an estimated $16K sold.

  • 57 institutional investors held Altimmune (ALT) as of Q2 2020, up from 29 in Q1 2020.
  • Funds reported $143M of Altimmune stock for Q2 2020, up 2,700% quarter-over-quarter.
  • 34 funds opened new Altimmune positions in Q2 2020 and 6 closed out, a net change of +28 holders.
  • The largest Altimmune buyer in Q2 2020 was VR Adviser, an estimated $24.7M added.
  • The largest Altimmune seller in Q2 2020 was Victory Capital Management, an estimated $16K sold.

Based on aggregated 13F filings for Q2 2020.